Mechanism of Formation of Polysulfane Anticancer Agents
聚硫烷抗癌剂的形成机理
基本信息
- 批准号:7059750
- 负责人:
- 金额:$ 11.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-01-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Ascidians (tunicates) contain compounds with a large range of pharmacological activities. With the most
common of chemical ingredients, elemental sulfur and dopamine, an ascidian has developed a means to
protect itself from predators using in essence chemical warfare. With lessons that marine organisms can
provide, how might chemists seek the advent of new therapeutic substances from abundant and simple
natural reagents? The problem is that we lack an understanding of the biosynthetic pathways that marine
organisms use to make protective or otherwise purposeful molecules from benign common precursors. A
long-term objective of this program is to synthesize sulfur?dopamine compounds that may have enhanced
biological activity compared to what nature provides. This proposal outlines an experimental and theoretical
organic chemistry approach to addressing the structure and synthesis of polysulfane antitumor compounds.
Mechanistic information will be sought in reactions that mimic a biosynthetic process to help in designing
new drugs. The goals of the research project are: (1) to examine the chemical mechanism for the formation
of natural product antitumor polysulfanes formed from dopamine, and determine the product yields and
product reaction profiles, (2) to identify the chemical form of sulfur that can add to dopamine and related
natural aromatics such as catechol, (3) to define certain steps in the mechanism of formation of the
polysulfur linkage, (4) to determine whether observed trends in heterocycle odd-even membered ring effects
serve as a guide in the synthesis of pharmaceutically active polysulfane molecules, (5) to synthesize
sulfur?dopamine compounds that have enhanced biological activity compared to what nature provides, and
(6) to establish a collaborative research program such that the molecules produced in our laboratory will be
examined as possible lead compounds, which may eventually be used clinically as antitumor and antibiotic
agents. Research design and methods will involve experiments that utilize HPLC, GC/MS, NMR, and kinetic
analyses for characterizations of the mechanisms. Theoretical calculations will be performed to discover the
factors that are likely to influence polysulfane synthesis and decomposition with the aim of evaluating the
viability of the intermediates.
海沿岸(双弯头)含有具有大量药理活性的化合物。最多
化学成分,元素硫和多巴胺的常见,海鞘已经开发了一种手段
保护自身免受本质化学战的捕食者的侵害。借助海洋生物可以
提供,化学家如何寻求新的治疗物质从丰富而简单的
天然试剂?问题是我们对海洋的生物合成途径缺乏了解
生物体用来从良性共同前体中产生保护性或有目的的分子。一个
该程序的长期目标是合成可能增强的硫的多巴胺化合物
与自然所提供的生物活性相比。该建议概述了实验和理论
有机化学方法来解决多硫烷抗肿瘤化合物的结构和合成。
将在模仿生物合成过程的反应中寻求机械信息,以帮助设计
新药。研究项目的目标是:(1)检查形成的化学机制
由多巴胺形成的天然产物抗肿瘤多硫硫硫硫代,并确定产物的产量和
产品反应曲线,(2)确定可以添加到多巴胺和相关的硫的化学形式
自然芳香剂,例如儿茶酚,(3),以定义形成机理的某些步骤
多硫连接,(4)确定观察到的杂环奇数构成环效应的趋势是否存在
作为合成药物活性多硫烷分子的指南,(5)合成
与自然所提供的相比,具有增强生物学活性的硫?多巴胺化合物,
(6)建立一个协作研究计划,以使我们实验室产生的分子将是
被检查为可能的铅化合物,最终可以在临床上用作抗肿瘤和抗生素
代理商。研究设计和方法将涉及使用HPLC,GC/MS,NMR和动力学的实验
分析机制的特征。将执行理论计算以发现
可能影响多硫代合成和分解的因素,目的是评估
中间体的生存能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
ALEXANDER GREER的其他基金
Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy
用于靶向牙科光动力治疗的超疏水植入表面和 3D 打印技术
- 批准号:93396569339656
- 财政年份:2016
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Superhydrophobic Implantable Surface and 3D Printing Technology for Targeted Dental Photodynamic Therapy
用于靶向牙科光动力治疗的超疏水植入表面和 3D 打印技术
- 批准号:92541179254117
- 财政年份:2016
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Site-specific delivery of photosensitizer and singlet oxygen in vivo
体内光敏剂和单线态氧的位点特异性递送
- 批准号:82699318269931
- 财政年份:2010
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Site-specific delivery of photosensitizer and singlet oxygen in vivo
体内光敏剂和单线态氧的位点特异性递送
- 批准号:84747868474786
- 财政年份:2010
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Site-specific delivery of photosensitizer and singlet oxygen in vivo
体内光敏剂和单线态氧的位点特异性递送
- 批准号:81141288114128
- 财政年份:2010
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Site-specific delivery of photosensitizer and singlet oxygen in vivo
体内光敏剂和单线态氧的位点特异性递送
- 批准号:79323987932398
- 财政年份:2010
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Mechanism of Formation of Polysulfane Anticancer Agents
聚硫烷抗癌剂的形成机理
- 批准号:75587727558772
- 财政年份:
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Mechanism of Formation of Polysulfane Anticancer Agents
聚硫烷抗癌剂的形成机理
- 批准号:75799017579901
- 财政年份:
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Mechanism of Formation of Polysulfane Anticancer Agents
聚硫烷抗癌剂的形成机理
- 批准号:77789067778906
- 财政年份:
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
相似国自然基金
生物产品多组分分离的动态吸附膜和静态吸附膜集成技术研究
- 批准号:20976175
- 批准年份:2009
- 资助金额:9.0 万元
- 项目类别:面上项目
转基因植物产品电化学生物传感器
- 批准号:20375020
- 批准年份:2003
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
A [3+2] Annulation Route to Annonaceous Acetogenins
A [3 2] 成环途径为番荔枝苷
- 批准号:66941746694174
- 财政年份:2003
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
A [3+2] Annulation Route to Annonaceous Acetogenins
A [3 2] 成环途径为番荔枝苷
- 批准号:67724186772418
- 财政年份:2003
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
ANTI-ANGIOGENIC MIMETICS FOR CANCER THERAPY
用于癌症治疗的抗血管生成模拟物
- 批准号:62878876287887
- 财政年份:2001
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Synthesis and Structure of Antitumor Agents
抗肿瘤药物的合成与结构
- 批准号:69170276917027
- 财政年份:1998
- 资助金额:$ 11.63万$ 11.63万
- 项目类别:
Synthesis and Structure of Antitumor Agents
抗肿瘤药物的合成与结构
- 批准号:70915597091559
- 财政年份:1998
- 资助金额:$ 11.63万$ 11.63万
- 项目类别: